Dr. Chin-Tarng Lin, D.D.S., Ph.D., has devoted several decades to perform molecular pathological cancer research. He was a pathology professor and is an Emeritus professor right now at the College of Medicine, National Taiwan University, Taiwan. He has published more than 92 papers and obtained 12 patents, and has been invited to give the scientific seminar over 75 times. He has presented 191 abstracts to attend the world-wide biomedical science meetings. His research interests include the development of immunohistochemical localization of protein, mRNA and DNA molecules at the light and electron microscopic levels and peptide histochemistry to identify the peptide targeted binding protein. He has established 10 nasopharyngeal carcinoma cell lines (NPC-TW-01 to-10) and five endometrioid cancer cell lines (OV-TW59-P0 to-P4) in his laboratory. His major interests are to investigate the molecular pathogenesis of NPC with or without Epstein-Barr virus infection and of ovarian cancer. He and his colleagues have identified 3 specific peptides to localize their targeted proteins, to identify the cancer xenograft by MRI and to perform peptide-targeted chemotherapy for different cancers with minimal adverse event. Peptide targeted MRI and chemotherapy for NPC, hepato-pancreatic and other cancers